Williams J C, Merguerian P A, Schned A R, Morrison P M
Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
J Urol. 1995 Feb;153(2):395-6. doi: 10.1097/00005392-199502000-00031.
Acquired renal cystic disease has been reported in the kidneys of patients with end stage renal disease who have been untreated, treated with dialysis or undergone renal transplantation. The incidence of renal tumor development in patients with acquired renal cystic disease is greater than 5% in those undergoing chronic hemodialysis. Recently, cases of renal cell carcinoma occurring with acquired renal cystic disease of the native kidneys of transplant recipients have been reported. Transplant patients have an increased incidence of malignancy when compared to the general population. Including our case, 19 cases of de novo renal neoplasms developing in renal allografts have been reported. To the best of our knowledge we report the longest interval to presentation of a de novo renal tumor in an allograft kidney (228 months) and the first case of renal cell carcinoma associated with acquired renal cystic disease in an allograft kidney.
据报道,在未经治疗、接受透析治疗或接受肾移植的终末期肾病患者的肾脏中会出现获得性肾囊肿病。在接受慢性血液透析的患者中,获得性肾囊肿病患者发生肾肿瘤的发生率大于5%。最近,有报道称移植受者的天然肾脏发生获得性肾囊肿病时会出现肾细胞癌病例。与普通人群相比,移植患者发生恶性肿瘤的发生率更高。包括我们的病例在内,已有19例同种异体肾移植中出现新发肾肿瘤的病例报道。据我们所知,我们报告了同种异体移植肾中出现新发肾肿瘤的最长间隔时间(228个月)以及首例同种异体移植肾中与获得性肾囊肿病相关的肾细胞癌病例。